Fatal Cerebral Edema With Status Epilepticus in Children With Dravet Syndrome: Report of 5 Cases
Overview
Authors
Affiliations
Dravet syndrome (DS) is a well-recognized developmental and epileptic encephalopathy associated with mutations and 15% mortality by 20 years. Although over half of cases succumb to sudden unexpected death in epilepsy, the cause of death in the remainder is poorly defined. We describe the clinical, radiologic, and pathologic characteristics of a cohort of children with DS and mutations who developed fatal cerebral edema causing mass effect after fever-associated status epilepticus. Cases were identified from a review of children with DS enrolled in the Epilepsy Genetics Research Program at The University of Melbourne, Austin Health, who died after fever-associated status epilepticus. Five children were identified, all of whom presented with fever-associated convulsive status epilepticus, developed severe brain swelling, and died. All had de novo mutations. Fever of 40°C or greater was measured in all cases. Signs of brainstem dysfunction, indicating cerebral herniation, were first noted 3 to 5 days after initial presentation in 4 patients, though were apparent as early as 24 hours in 1 case. When MRI was performed early in a patient's course, focal regions of cortical diffusion restriction were noted. Later MRI studies demonstrated diffuse cytotoxic edema, with severe cerebral herniation. Postmortem studies revealed diffuse brain edema and widespread neuronal damage. Laminar necrosis was seen in 1 case. Cerebral edema leading to fatal brain herniation is an important, previously unreported sequela of status epilepticus in children with DS. This potentially remediable complication may be a significant contributor to the early mortality of DS.
Developmental and epileptic encephalopathies.
Scheffer I, Zuberi S, Mefford H, Guerrini R, McTague A Nat Rev Dis Primers. 2024; 10(1):61.
PMID: 39237642 DOI: 10.1038/s41572-024-00546-6.
Case report: Invasive neuromonitoring in status epilepticus induced hypoxic ischemic brain injury.
Bhatti K, Rajagopalan S Front Neurol. 2023; 14:1284098.
PMID: 38099068 PMC: 10720614. DOI: 10.3389/fneur.2023.1284098.
Donnan A, Schneider A, Russ-Hall S, Churilov L, Scheffer I Neurology. 2023; 100(16):e1712-e1722.
PMID: 36750385 PMC: 10115508. DOI: 10.1212/WNL.0000000000207080.
Guidance on Dravet syndrome from infant to adult care: Road map for treatment planning in Europe.
Cardenal-Munoz E, Auvin S, Villanueva V, Cross J, Zuberi S, Lagae L Epilepsia Open. 2021; 7(1):11-26.
PMID: 34882995 PMC: 8886070. DOI: 10.1002/epi4.12569.
Defining Dravet syndrome: An essential pre-requisite for precision medicine trials.
Li W, Schneider A, Scheffer I Epilepsia. 2021; 62(9):2205-2217.
PMID: 34338318 PMC: 9291974. DOI: 10.1111/epi.17015.